Summit Clinical Research

Summit Clinical Research is a physician-founded IRO supporting Phase II–III trials in SLD, obesity, and Alzheimer’s. We offer site activation, recruitment, biostats, and more, backed by 120+ global sites, 70+ sponsors, and 60+ clinical trials. We connect science, strategy, and execution to accelerate clinical trials that matter. We are an Integrated Research Organization (IRO) focused on advancing treatments in steatotic liver disease (SLD), obesity, and Alzheimer’s disease. Founded by physicians and supported by key opinion leaders, we bring deep therapeutic expertise and hands-on operational support to every program. For sponsors, we provide Phase II and III trial services including protocol design, global site activation, patient recruitment, statistical programming, and operational oversight. Our model is built for teams that want to move quickly without compromising scientific quality. For sites, we offer a true partnership with clear communication, aligned goals, and the resources needed to enroll and retain the right patients. Our network includes experienced investigators, hepatologists, and community-based practices across eight countries. As of 2025, Summit has supported: • More than 60 clinical trials • Over 70 biopharma sponsors • 120 research sites across 8 countries Whether you are planning your first steatohepatitis study or expanding a global program, we bring the right combination of medical insight and operational strength to help you move forward. Headquartered in San Antonio and working worldwide.